Zhang Yizhe, Zhu Chaoyin, Zhao Hongjun, Sun Zhanyang, Wang Xiaodi
School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
Mengzhou Nongda biochemical products Co., Ltd, Jiaozuo city, China.
Int J Med Microbiol. 2023 Mar;313(2):151576. doi: 10.1016/j.ijmm.2023.151576. Epub 2023 Jan 24.
Pneumonia is an inflammation-related respiratory infection and chlorogenic acid (CGA) possesses a wide variety of bioactive properties, such as anti-inflammation and anti-bacteria.
This study explored the anti-inflammatory mechanism of CGA in Klebsiella pneumoniae (Kp)-induced rats with severe pneumonia.
The pneumonia rat models were established by infection with Kp and treated with CGA. Survival rates, bacterial load, lung water content, and cell numbers in the bronchoalveolar lavage fluid were recorded, lung pathological changes were scored, and levels of inflammatory cytokines were determined by enzyme-linked immunosorbent assay. RLE6TN cells were infected with Kp and treated with CGA. The expression levels of microRNA (miR)-124-3p, p38, and mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in lung tissues and RLE6TN cells were quantified by real-time quantitative polymerase chain reaction or Western blotting. The binding of miR-124-3p to p38 was validated by the dual-luciferase and RNA pull-down assays. In vitro, the functional rescue experiments were performed using miR-124-3p inhibitor or p38 agonist.
Kp-induced pneumonia rats presented high mortality, increased lung inflammatory infiltration and the release of inflammatory cytokines, and enhanced bacterial load, while CGA treatment improved rat survival rates and the above situations. CGA increased miR-124-3p expression, and miR-124-3p inhibited p38 expression and inactivated the p38MAPK pathway. Inhibition of miR-124-3p or activation of the p38MAPK pathway reversed the alleviative effect of CGA on pneumonia in vitro.
CGA upregulated miR-124-3p expression and inactivated the p38MAPK pathway to downregulate inflammatory levels, facilitating the recovery of Kp-induced pneumonia rats.
肺炎是一种与炎症相关的呼吸道感染,而绿原酸(CGA)具有多种生物活性特性,如抗炎和抗菌。
本研究探讨CGA对肺炎克雷伯菌(Kp)诱导的重症肺炎大鼠的抗炎机制。
通过感染Kp建立肺炎大鼠模型并用CGA进行治疗。记录生存率、细菌载量、肺含水量以及支气管肺泡灌洗液中的细胞数量,对肺部病理变化进行评分,并通过酶联免疫吸附测定法测定炎症细胞因子水平。用Kp感染RLE6TN细胞并用CGA进行处理。通过实时定量聚合酶链反应或蛋白质免疫印迹法对肺组织和RLE6TN细胞中微小RNA(miR)-124-3p、p38和丝裂原活化蛋白激酶(MAPK)激活的蛋白激酶2(MK2)的表达水平进行定量。通过双荧光素酶和RNA下拉试验验证miR-124-3p与p38的结合。在体外,使用miR-124-3p抑制剂或p38激动剂进行功能挽救实验。
Kp诱导的肺炎大鼠呈现高死亡率、肺部炎症浸润增加、炎症细胞因子释放增多以及细菌载量增加,而CGA治疗提高了大鼠生存率并改善了上述情况。CGA增加了miR-124-3p的表达,并且miR-124-3p抑制了p38的表达并使p38MAPK通路失活。抑制miR-124-3p或激活p38MAPK通路可逆转CGA在体外对肺炎的缓解作用。
CGA上调miR-124-3p表达并使p38MAPK通路失活以下调炎症水平,促进Kp诱导的肺炎大鼠的恢复。